Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

APT-KIDNEY: The Adaptive Platform Trial for Kidney Disease

NCT07595952 is registered in ClinicalTrials.gov with Nicholas Carlson as lead sponsor.

NCT NCT07595952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07595952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
APT-KIDNEY: The Adaptive Platform Trial for Kidney Disease
Lead sponsor
Nicholas Carlson
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
December 31, 2066
Enrollment
5,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease (stages 4 and 5), dialysis, end-stage kidney disease (eskd), kidney disease, kidney transplantation